Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 17
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Approved-not yet active
18 and over
Other
GE-196-001
NCT00785694
Last Modified:
3/27/2007
 
First Published:
10/1/2001
2.
Phase III Randomized Study of Radiotherapy and Fluorouracil With Either Mitomycin or Cisplatin and With or Without Maintenance Therapy in Patients With Primary Epidermoid Anal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Not specified
Other
NCRI-ACT-II
EU-20056, UKCCCR-ACT-II, ISRCTN26715889, NCT00025090
3.
A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 70
Other
T1303
NCT00201396
4.
Trial of Adjuvant Chemotherapy for Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 to 69
Other
AMC-ONCGI-0102
NCT00296322
5.
Trial of Adjuvant Chemotherapy for Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 to 69
Other
AMC-ONCGI-0204
NCT00296335
6.
A Prospective,Multi-Center,Randomized Control Trial of Preoperative Hepatic and Regional Arterial Chemotherapy(PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Approved-not yet active
18 to 74
Other
2008-46
no, NCT00643877
7.
Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG for Superficial Bladder Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Not specified
Pharmaceutical / Industry
102.1
NCT00384891
Last Modified:
7/28/2008
 
First Published:
11/1/2002
8.
Phase II Randomized Study of Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma Receiving Chemoembolization
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
UCLA-0206060
02-06-060, NCI-G02-2124, NCT00049322
9.
A Phase II Study of Intra-Arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
3L-03-1
NCT00183885
Last Modified:
6/22/2007
 
First Published:
1/6/2006
10.
Phase II Study of an Individualized Drug Treatment Selection Process Based on a Tumor Xenograft Model for Patients With Resectable Pancreatic Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
JHOC-J0507
JHOC-05041402, NCT00276744
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute